Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection

T Xiang, B Liang, H Wang, X Quan, S He… - Cellular & molecular …, 2021 - nature.com
… in compensated cirrhotic patients still outweighs the vaccine-related risk. Next, we determined
the immunogenicity of CHB patients who completed the two doses of the vaccination

Nonhuman primate models to evaluate vaccine safety and immunogenicity

RC Kennedy, MH Shearer, W Hildebrand - Vaccine, 1997 - Elsevier
… a number of human infectious diseases and tumors… vaccine safety and immunogenicity are
briefly discussed. Comparative immunology, reproductive physiology, endogenous infectious

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

AR Falsey, EE Walsh - Vaccine, 1996 - Elsevier
… RSV infections in the placebo group and none in the vaccine group. Thus, PFP-2 was found
to be safe and immunogenic in healthy older adults. Copyright 0 1996 Elsevier Science Ltd. …

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries

PA Patriarca, PF Wright, TJ John - Reviews of infectious …, 1991 - academic.oup.com
vaccine virus and enteric pathogens often interfere with responses to types 1 and 3 vaccine
viruses … , in view of the prolonged excretion of vaccine virus and the potential for interference …

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against chikungunya virus

C López-Camacho, Y Chan Kim, J Blight… - Viruses, 2019 - mdpi.com
… tested the immunogenicity of our viral-vectored vaccines by … Our data shows that the T
cell immunogenicity elicited by … licensed vaccine is yet available to prevent CHIKV infection. …

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old

DA Tristram, RC Welliver, CK Mohar… - Journal of Infectious …, 1993 - academic.oup.com
… in the cotton rat model ofRSV infection [4, 5]. The present study was undertaken to evaluate
the safety and immunogenicity of an RSV F protein vaccine in previously infected 18- to 36-…

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

SE Frey, M Houghton, S Coates, S Abrignani, D Chien… - Vaccine, 2010 - Elsevier
… for an effective vaccine to protect against infection and/or disease due to hepatitis C virus
(HCV… system is that the vaccine may not be strongly immunogenic for virus neutralization, there …

Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012–2013

S Cobey, S Gouma, K Parkhouse… - Clinical Infectious …, 2018 - academic.oup.com
… Influenza vaccination aims to prevent infection by influenza virus and reduce associated …
the vaccine strain. Instead, low VE might have been caused by low vaccine immunogenicity in a …

Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination

B Pozzetto, V Legros, S Djebali, V Barateau, N Guibert… - Nature, 2021 - nature.com
… mice have demonstrated the strong immunogenicity of the ChAd–… vaccination confers better
protection against infection—which is associated with more switched mBCs and higher virus

Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity …

SA Madhi, M Maskew, A Koen… - Clinical infectious …, 2011 - academic.oup.com
… , inactivated influenza vaccine (TIV) in HIV-infected adults, particularly in Africa, are limited.
This study evaluated the safety, immunogenicity, and efficacy of TIV in HIV-infected adults. …